aTyr Pharma | LIFE - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Alterity Therapeutics Limited AUD 22.81M 5.29M 2023-06
Ardelyx USD 166.95M 12.67M 2025-12
aTyr Pharma USD 80.24M 5.58M 2025-09
Biogen USD 18.21B 573.5M 2025-09
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Cipla INR 329.19B 16.3B 2025-09
Clal Biotechnology ILS 121.41M 4.62M 2023-12
Compugen USD 43.83M 6.43M 2025-09
CSL USD 18.66B 2.75B 2025-12
Curis USD -13.99M 7.38M 2025-06
Galapagos EUR 3.24B 788.91M 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
Grifols EUR 6.08B 34.72M 2025-09
Novartis USD 44.75B 2.7B 2025-09
Roche Holding CHF 33.8B 758M 2025-12
United Therapeutics USD 7.1B 506M 2025-12
Xoma USD 87.94M 15.5M 2025-09